Equivalent To TCI A0661: Polymorphic Crystallization Control
Polymorphic Landscape of 2-Amino-4-chlorobenzoic Acid: Monoclinic vs. Orthorhombic Crystal Habits and Their Impact on Filtration Performance
2-Amino-4-chlorobenzoic acid, also known as 4-chloroanthranilic acid, is a critical benzoic acid derivative used in pharmaceutical and agrochemical synthesis. Its crystallization behavior is dominated by two polymorphs: a monoclinic form (Form I) and an orthorhombic form (Form II). These crystal habits are not merely academic curiosities; they directly influence downstream processing. Form I typically crystallizes as thin plates that can blind filters, while Form II often yields more equant crystals with superior filtration rates. During pilot scale-up, the challenge is to consistently produce the desired polymorph to match the performance of reference standards like TCI America A0661. Our manufacturing process, refined over numerous campaigns, ensures that the polymorphic outcome is predictable and controllable, providing a drop-in replacement for your existing process. For those working with kinase inhibitor synthesis, trace metal limits are equally critical, as discussed in our article on substituto direto para Sigma-Aldrich A45467.
Cooling Rate Thresholds and Solvent Ratio Optimization to Control Particle Size Distribution During Recrystallization Scale-Up
The interplay between cooling rate and solvent composition is the primary lever for controlling crystal size and habit. In our experience, a cooling rate exceeding 0.5°C/min from 60°C to 5°C in a water/ethanol mixture (60:40 v/v) tends to nucleate Form I exclusively, but with a broad particle size distribution that includes fines. Slower cooling (0.1–0.2°C/min) promotes the growth of larger, more uniform Form II crystals. However, a non-standard parameter we've observed is the effect of trace water content in the ethanol: even a 2% variation can shift the metastable zone width, leading to unexpected nucleation of a mixed phase. Our process engineers have mapped these thresholds to ensure that every batch of 2-amino-4-chlorobenzoic acid meets the particle size specifications required for seamless integration as an equivalent to TCI A0661. This level of control is essential for maintaining consistent bulk density and flowability in automated dispensing systems. For a deeper dive into trace metal considerations in similar chemistries, see our analysis on прямая замена для Sigma-Aldrich A45467.
Batch-Specific COA Parameters: Purity, Polymorph Ratio, and Particle Size Specifications for Seamless TCI A0661 Replacement
When qualifying a new source of 2-amino-4-chlorobenzoic acid, R&D managers must scrutinize the certificate of analysis (COA) beyond simple HPLC purity. Our COA includes polymorph ratio determined by XRPD, with a typical specification of ≥95% Form II. We also report particle size distribution (D10, D50, D90) via laser diffraction, ensuring that the material handles identically to the reference standard. The table below compares our typical batch data against the key parameters you would expect from TCI America A0661.
| Parameter | Our Specification | Typical TCI A0661 Value |
|---|---|---|
| Purity (HPLC) | ≥99.0% | ≥98.0% |
| Polymorph (XRPD) | Form II ≥95% | Form II dominant |
| Particle Size D50 | 50–150 µm | Not specified |
| Melting Point | 231–234°C | 231–234°C |
| Loss on Drying | ≤0.5% | ≤0.5% |
Please refer to the batch-specific COA for exact values. This transparency allows you to validate our 4-chloroanthranilic acid as a true drop-in replacement without costly process revalidation. Our quality assurance team can also provide custom synthesis support if your application requires a specific polymorphic purity or particle size range.
Bulk Packaging and Handling Protocols to Preserve Crystal Habit Integrity from Pilot to Production Scale
Maintaining the engineered crystal habit during storage and transport is as important as the crystallization itself. 2-Amino-4-chlorobenzoic acid crystals, particularly the orthorhombic form, are susceptible to attrition if subjected to excessive vibration or humidity. We package our material in anti-static, double-lined 25 kg fiber drums or 210L steel drums with desiccant bags to mitigate moisture uptake. For larger quantities, we offer 500 kg supersacks with conductive liners. Our logistics team ensures that the product is shipped in climate-controlled containers when necessary, preventing temperature excursions that could induce polymorphic transformation. We do not claim any specific environmental certifications, but our packaging is designed to preserve the physical integrity of the crystals from our warehouse to your reactor. This attention to detail ensures that the bulk density and flow characteristics you qualified in the lab are maintained at production scale.
Frequently Asked Questions
How does the polymorphic form affect the DSC melting point of 2-amino-4-chlorobenzoic acid?
The monoclinic Form I typically shows a melting endotherm at approximately 231°C, while the orthorhombic Form II melts around 233–234°C. A mixed phase may exhibit a broadened peak or a small endotherm preceding the main melt. Our COA reports the melting point range, and we can provide DSC thermograms upon request to confirm polymorphic purity.
What is the optimal anti-solvent addition rate to control crystal size during drowning-out crystallization?
For a water/ethanol system, adding water as the anti-solvent at a rate of 1–2 mL/min per liter of batch volume, with vigorous agitation, typically yields a narrow particle size distribution. Faster addition can cause local supersaturation and nucleation of fines. Our technical support team can provide a detailed protocol tailored to your equipment.
How does crystal morphology affect bulk density and hopper flow in production?
Platy crystals (Form I) tend to pack poorly, resulting in lower bulk density (around 0.3–0.4 g/mL) and bridging in hoppers. The more equant Form II crystals have a higher bulk density (0.5–0.6 g/mL) and flow more freely. Our specification targets Form II to ensure consistent feeding in automated synthesis platforms.
Sourcing and Technical Support
As a global manufacturer of 2-amino-4-chlorobenzoic acid, NINGBO INNO PHARMCHEM CO.,LTD. offers a stable supply of this key intermediate with the polymorphic control necessary for demanding pharmaceutical applications. Our product serves as a cost-effective, high-purity equivalent to TCI America A0661, backed by batch-specific COAs and expert technical support. Whether you need a single drum for R&D or multi-ton quantities for commercial production, we ensure consistent quality and reliable logistics. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.